News | Artificial Intelligence | December 04, 2018

Mirada Medical Joins U.K. Consortium Exploring Healthcare AI

Company will be working with U.K institutions to advance development and adoption of artificial intelligence in radiotherapy treatment planning and diagnostic nuclear medicine

Mirada Medical Joins U.K. Consortium Exploring Healthcare AI

December 4, 2018 — Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI) consortium receiving £50M in new funding from the U.K. government. The funding is part of the government’s drive to expedite the development and adoption of AI in healthcare and the National Health System (NHS).

Mirada developed the first deep learning applications for radiotherapy planning to receive regulatory clearance for clinical use in both Europe and the U.S. The company will bring its expertise and practical experience to projects hosted by Kings College London and the University of Oxford, two of the five centers funded through Wave 2 of the Industrial Strategy Challenge Fund’s ‘Data to Early Diagnosis and Precision Medicine’initiative.

Mirada will be partnering with the London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare, led by Kings College London, and will be working closely with Guys & St Thomas hospital. Mirada will be building on its success in commercializing its DLCExpert radiation therapy planning application to deliver the potential of AI to the NHS and demonstrate how advanced medical imaging and deep learning technologies can be used to improve patient care.    

Mirada will also partner with the University of Oxford’s NCIMI (National Consortium of Intelligent Medical Imaging) to investigate the role that AI and deep learning can play in diagnostic nuclear medicine. The company will be building on its established partnership with the Alliance Medical Group and the NHS positron emission tomography (PET) scanning program, where Mirada software is already used to read more than half of the PET/CT (computed tomography) scans in England & Wales.

These initiatives will improve the efficiency of cancer detection and diagnosis, leading to faster cancer treatment delivery, cost reductions for the NHS and improved patient outcomes.

Centre Director Professor Reza Razavi from King’s College London said: “The centre will provide a fantastic opportunity to transform 12 different patient pathways by using advanced imaging and AI and help make the products that will substantially improve the experience for our patients and their clinical outcomes. It will also allow us to better utilize the resources within the NHS. This builds on a great ongoing partnership between our researchers, clinicians and industry colleagues that will help put the UK at the forefront of developing and applying new technologies to improve healthcare.”

For more information: www.mirada-medical.com

Related Content

NVIDIA Launches Clara AI Toolkit for Algorithm Development
News | Artificial Intelligence | March 25, 2019
NVIDIA introduced Clara AI, a toolkit that includes 13 classification and segmentation artificial intelligence (AI)...
Videos | Radiology Business | March 22, 2019
American Society of Radiologic Technologists (ASRT) President Melissa Jackowski, Ed.D., R.T.(R)(M), FASRT, explains e
NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
FDA Clears Mobilett Elara Max Mobile X-ray from Siemens Healthineers
Technology | Digital Radiography (DR) | March 20, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Mobilett Elara Max mobile X-ray system from Siemens...
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...